Tag Archives: Cure Disease

Aaron Kowalski, PhD, CEO of JDRF, Brings His Professional & Personal Experience to StartUp Health’s T1D Moonshot Impact Board

October 25, 2022Business, Health, Innovation, StartupsAaron Kowalski, Cure Disease, diabetes, Health Moonshots, JDRF, JDRF International, Logan Plaster, T1D, T1D Moonshot, Type 1 Diabetes, Type 1 Diabetes MoonshotNicole Kinsey

Podcast: Play in new window | Download (Duration: 19:40 — 22.5MB)

For this StartUp Health NOW episode, we are joined by Aaron Kowalski, PhD, the CEO of JDRF International. Anyone orbiting in the universe of Type 1 diabetes will know that JDRF is the world’s largest nonprofit funder of T1D research. In his role atop the organization, Kowalski has combined his professional experience as a molecular biologist and executive with his personal passion to fight Type 1 diabetes in order to impact patients like his own brother.

Kowalski is also a recent addition to StartUp Health’s Type 1 Diabetes Moonshot Impact Board. This board is a cross-disciplinary team of T1D experts spanning the gamut from research to funding to commercialization. We are thrilled that Kowalski is bringing his vast experience to this cohort in order to speed up innovation and support a generation of health entrepreneurs.

Join us at the StartUp Health Festival @ HLTH, Nov 13-16 in Las Vegas, to learn more and get involved with our T1D Moonshot.

Entrepreneurs: How to get investment from StartUp Health startuphealth.com

Investors: How to invest in StartUp Health Moonshots healthmoonshots.com
Want more content like this? You can subscribe to the podcast as well as other health innovation updates at startuphealth.com/content.
Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.

Passionate about Type 1 diabetes? If you’re an entrepreneur or investor, contact us to learn how you can join our T1D Moonshot.

Looking to break down health barriers? If you’re an entrepreneur or investor, contact us to learn how you can join our Health Equity Moonshot.

AI-Powered Health: Naheed Kurji of Cyclica Takes a Deep Dive into Artificial Intelligence for the Healthcare Industry

October 18, 2022Business, Health, Innovation, StartupsAI, artificial intelligence, Cost to Zero, Cure Disease, Cyclica, Health Transformers, Logan Plaster, machine learning, Moonshots, Naheed KurjiNicole Kinsey

Podcast: Play in new window | Download (Duration: 35:28 — 40.6MB)

Our guest this week is Naheed Kurji, the CEO and Co-founder of Cyclica, which joined StartUp Health way back in 2014. He’s going to get us up to speed on the world of AI-powered drug discovery. We’ll learn how artificial intelligence and machine learning are speeding up our ability to identify molecules and find new uses for market-tested drugs. Naheed will give us an inside look at how Cyclica is specifically trying to reshape this market, then he’ll zoom way out. As the chair of the Alliance for Artificial Intelligence in Health, Naheed can help us understand where the AI for health industry is going.

Join us at the StartUp Health Festival @ HLTH, Nov 13-16, 2022, in Las Vegas to meet Naheed Kurji in person.

Learn more and connect with the team at Cyclica.

Entrepreneurs: How to get investment from StartUp Health startuphealth.com

Passionate about Type 1 diabetes? If you’re an entrepreneur or investor, contact us to learn how you can join our T1D Moonshot.

Looking to break down health barriers? If you’re an entrepreneur or investor, contact us to learn how you can join our Health Equity Moonshot.

How Brian Neman Has Cultivated an Award-Winning Workplace at Sanguine Biosciences

October 4, 2022Business, Health, Innovation, Startupsbiopharma, Brian Neman, COVID19, Cure Disease, Forbes, Health Moonshot, Health Transformer, Logan Plaster, Pandemic Response, Sanguine Biosciences, StartUp HealthNicole Kinsey

Podcast: Play in new window | Download (Duration: 24:12 — 27.7MB)

This week, our guest is Brian Neman, the CEO and Founder of Sanguine Biosciences, a company that joined the StartUp Health portfolio in 2018.

Brian and his team first made a splash by bringing an at-home on-demand business model to specimen collection for clinical trials. Instead of having to get yourself to a lab, you tap a few buttons on your phone and a nurse shows up at your house to take your blood. That business has evolved significantly over the years, which we’ll get into in the interview. But the spark for this interview had more to do with people than products.

You see, Brian’s company was just selected for the Forbes list of 100 Best Small Workplaces and top 10 in biopharma. Sanguine was also on Inc.’s list of fastest growing private companies, and Comparably named him on their list of best CEOs for women and for diversity in the workplace.

In this interview, Brian will talk about how he cultivates company culture, particularly in an era of remote work – and he had loads of wisdom to share, so we hope you enjoy.

Connect with the team at Sanguine Biosciences via email.

Entrepreneurs: How to get investment from StartUp Health startuphealth.com

Passionate about Type 1 diabetes? If you’re an entrepreneur or investor, contact us to learn how you can join our T1D Moonshot.

Looking to break down health barriers? If you’re an entrepreneur or investor, contact us to learn how you can join our Health Equity Moonshot.

Health Innovation Implementation: Dr. Robert Wilson on How Partnering with PreventScripts Enhanced His Medical Practice

September 27, 2022Business, Health, Innovation, StartupsAccess to care, Brandi Harless, chronic care, Cost to Zero, CovenantCare, CovenantCare Family Practice, Cure Disease, diabetes, Digital Health, Dr. Natalie Davis, Dr. Robert Wilson, health innovation, Health Moonshots, health transformation, Health Transformers, Logan Plaster, md, Natalie Davis, PreventScripts, Robert Wilson, Type 2 Diabetes, Type II DiabetesNicole Kinsey

Podcast: Play in new window | Download (Duration: 22:39 — 21.2MB)

Typically on this show we talk to the health tech founders – who we call Health Transformers – that are creating the tools and platforms that will modernize our health system. This week we have a different kind of guest who will help round out the picture of how healthcare innovation goes from idea to real-world implementation.

Our guest is Robert Wilson, MD, a family physician who runs CovenantCare Family Practice, a multi-site medical practice in Tennessee. Dr. Wilson popped up on our radar because he was an early partner for PreventScripts, a startup that’s part of the StartUp Health portfolio. PreventScripts, led by Brandi Harless and Natalie Davis, MD, has created a platform that helps family doctors like Dr. Wilson identify patients who would benefit from chronic care management. Think about a patient who is pre-diabetic and all signs point towards a long battle with Type 2 diabetes. While Dr. Wilson might be too overextended to identify and coach this patient before the disease sets in, PreventScripts can identify the risk and put the patient on a clinically-proven program. Patients with chronic diseases, or the risk of disease, get heightened care between visits, and Dr. Wilson gets added reimbursement.

We wanted to talk to Dr. Wilson to understand why he was interested in partnering with a health startup, as this is one of the key hurdles for any health innovator. How do you find the right clinical partner, a place to prove out your brilliant idea in the real world, and then iterate based on user feedback?

In the conversation, we’ll get into the real-world challenges that Dr. Wilson faces, his motivation for evolving his practice, and how PreventScripts has helped him fill gaps in patient care.

Learn more and connect with the team at PreventScripts.

Entrepreneurs: How to get investment from StartUp Health startuphealth.com

Passionate about Type 1 diabetes? If you’re an entrepreneur or investor, contact us to learn how you can join our T1D Moonshot.

Looking to break down health barriers? If you’re an entrepreneur or investor, contact us to learn how you can join our Health Equity Moonshot.

Former Dexcom Exec Claudia Graham Joins StartUp Health’s New T1D Moonshot Impact Board

August 9, 2022Business, Health, Innovation, StartupsClaudia Graham, Cure Disease, Dexcom, diabetes, Diabetes Moonshot, Health Moonshots, StartUp Health, Type 1 Diabetes, Type 1 Diabetes MoonshotNicole Kinsey

Podcast: Play in new window | Download (Duration: 17:19 — 23.8MB)

“The more you know, the better you’ll do living with diabetes,” says Claudia Graham. “There’s nothing more important in diabetes than empowering patients.”

If you follow StartUp Health at all, you have seen headlines about our new Type 1 Diabetes Moonshot. To recap, we’ve launched an initiative designed to speed up innovation around Type 1 diabetes by bringing together a cross-disciplinary team of investors, entrepreneurs, philanthropists, researchers, and other industry experts. At the heart of the effort is an Impact Board – basically our T1D dream team – which brings together the top minds in the field for collaborative working sessions. We wanted to take some time on this podcast to introduce you to some of the inspiring folks on this Impact Board and invite you to get involved in the effort.

On this episode you’ll meet Claudia Graham, former executive at Dexcom, the company that revolutionized the continuous glucose monitor. She served as VP of Marketing and SVP of Global Access. Now she’s putting her decades of experience at Dexcom – and as someone living with Type 1 diabetes – to work as an advisor and investor. We caught up with Claudia over zoom at her home in Idaho to learn about the opportunities and challenges she sees in the Type 1 Diabetes Moonshot, how StartUp Health helps get away from institutional thinking to break down barriers and empower patients, and how she thinks about leaving a legacy for the next generation.

Entrepreneurs, are you working on a T1D solution? We want to hear from you.
Investors, want to back an impact-driven fund laser focused on T1D? Contact us.

Want more content like this? You can subscribe to the podcast as well as other health innovation updates at startuphealth.com/content.
Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.

Health Transformers Live: Gray Oncology Solutions, Gennev, AvoMD, Valera Health

April 5, 2022Business, Health, Innovation, Insights, Startups2022 StartUp Health Festival, Access to care, Cancer, Cure Disease, End Cancer, Health Moonshots, Lauren Schafer, mental health, Moonshots, StartUp Health @ ViVE, StartUp Health Festival, ViVE 2022, ViVE Miami, womens healthNicole Kinsey

Podcast: Play in new window | Download (Duration: 19:29 — 17.9MB)

This week we wanted to break from our typical format and introduce you to four inspiring founders from the StartUp Health portfolio.

This episode is excerpted from an on-stage Health Transformer discussion that was held at the StartUp Health Festival @ ViVE in Miami Beach in March. You’ll hear from André Diamant, PhD, CEO & Founder of Gray Oncology Solutions, about how they’re improving efficiency in cancer care. Jill Angelo, CEO & Founder of Gennev, talks about how they’re improving women’s health in their post-reproductive years. Yair Saperstein, MD, CEO & Co-founder of AvoMD, explains how they’re crowdsourcing knowledge in order to put the best decision support tools in the palm of the physician’s hand. And finally, Tom Tsang, MD, CEO & Co-founder of Valera Health, explains how his company is bringing comprehensive mental health services to the virtual healthcare ecosystem.

The session was hosted by Lauren Schafer from StartUp Health. In addition to sharing the moonshot missions of each of their companies, they talk about changes seen in health innovation due to COVID’s impact, their biggest messages for partners and investors, and more.

Entrepreneurs: How to get investment from StartUp Health startuphealth.com

How Nightingale Is Redefining Preventative Health

February 8, 2022Business, Health, Innovation, Insights, Startups, UncategorizedAI, Blood Testing, Cure Disease, diabetes, Finland, Health Moonshot Update, Health Moonshots, Health Tech, Heart Disease, Logan Plaster, Longevity, Moonshots, Nightingale, Teemu Suna, TelehealthNicole Kinsey

Podcast: Play in new window | Download (Duration: 39:50 — 36.5MB)

Join us in Miami Beach in March for StartUp Health @ ViVE 2022: startuphealth.com/vive

Nightingale Health, a Finnish company that StartUp Health backed in 2016, uses a new kind of blood testing to predict future disease risk so that people can change the course of their health before it’s too late. They’ve designed a way to analyze blood samples that pulls 250 times more data from that sample than a typical test. They use artificial intelligence and machine learning to correlate that data with future disease risk, like diabetes and heart disease. Then they put the result in simple terms so that patients can see trends and take action.

This year, Nightingale took three big strides forward. They went public on the Finnish Nasdaq, which gave them capital to scale globally. They rolled out at-home testing kits so more people can benefit from Nightingale’s disease prediction. And they acquired a genomics company that will allow them to bake genetic information into their app and provide people with even more personalized health assessments.

We sat down with Nightingale CEO and Co-founder Teemu Suna to hear more about their blood testing technology and how it could change preventative health globally by getting patients to see their potential future and then change the course of their health.

Join us in Miami Beach in March at StartUp Health @ ViVE 2022 to meet Health Transformers: startuphealth.com/vive

—

Learn more and connect with the team at Nightingale.

Entrepreneurs: How to get investment from StartUp Health startuphealth.com

Responsum Health’s Latest App Puts Long-COVID Front and Center

January 10, 2022Business, Health, Innovation, Insights, Startups, UncategorizedAccess to care, coronavirus, Covid, Covid 19, COVID19, Cure Disease, Health Moonshot Update, Health Moonshots, Logan Plaster, Pandemic Response, Responsum HealthNicole Kinsey

Podcast: Play in new window | Download (Duration: 21:14 — 19.5MB)

Our guest today is Andrew Rosenberg, CEO and Founder of Responsum Health, which StartUp Health backed in 2019. At Responsum, Rosenberg and his team have created disease-specific apps that bring together curated information and news about that disease as well as a professionally-moderated community chat, so patients can connect and learn in a safe environment. Their recent app developed around Long-COVID has exploded with activity, so we sat down with Rosenberg to hear what he’s learning from this community of patients.

Join us in Miami Beach in March at StartUp Health @ ViVE 2022 and meet Andrew Rosenberg and other Health Transformers: startuphealth.com/vive

—

Entrepreneurs: How to get investment from StartUp Health startuphealth.com

Reversing Diabetes With Sami Inkinen of Virta Health

January 4, 2022Business, Health, Innovation, Insights, StartupsCure Disease, diabetes, Health Moonshot Update, Health Moonshots, Logan Plaster, Moonshots, Sami Inkinen, Type 2 Diabetes, Type II Diabetes, Virta, Virta HealthNicole Kinsey

Podcast: Play in new window | Download (Duration: 36:58 — 50.8MB)

Join us in Miami Beach from March 6-9, 2022, for StartUp Health @ ViVE to meet Health Transformers: startuphealth.com/vive

The numbers surrounding Type 2 diabetes are staggering. The WHO puts the number north of 400 million people globally, and it’s just getting worse. Health experts agree that Type 2 diabetes can largely be managed by a combination of nutrition, exercise, and medication. But what if it could be reversed completely? That’s the claim, and the health moonshot, of our guest today, Sami Inkinen, CEO and Founder of Virta, which StartUp Health backed in 2020. Specifically, Inkinen and his team want to reverse Type 2 diabetes in 100 million people by 2025.

Before Virta, Inkinen disrupted the real estate industry by co-founding Trulia, which he sold to Zillow for $2.5B. Now with Virta, he’s raised more than $350M to date, giving him the capital needed to take a great idea and scale it in unprecedented ways.

—

Entrepreneurs: How to get investment from StartUp Health startuphealth.com

For Ironman Athlete David Weingard, a Diabetes Diagnosis Was a Spark for Innovation

November 30, 2021Business, Health, Innovation, Insights, Startups, UncategorizedAccess to care, Cecelia Health, Cure Disease, David Weingard, diabetes, Health Moonshot Update, Health Moonshots, Logan Plaster, Startup, StartUp HealthStartUp Health NOW

Podcast: Play in new window | Download (Duration: 36:42 — 50.4MB)

Join us in Miami Beach from March 6-9, 2022, for StartUp Health @ ViVE to meet the Cecelia Health team and other Health Transformers: startuphealth.com/vive

===

Today, you’d be hard-pressed to find anyone who hasn’t been impacted by diabetes in some way. Globally, half a billion people are affected by the disease, and it was responsible for the deaths of 1.5M people globally in 2019. As frightening as those numbers are, there is also great hope to be found today in the entrepreneurs and innovations changing how we manage diabetes. To understand both sides of this coin – the very personal toll of diabetes plus the present and future promise of health technology – we talked to David Weingard, founder of Cecelia Health, which helps diabetics get the specialized health coaching they need. More importantly, David is a type 1 diabetic who has fought for his own life and knows the daily fears and challenges that this silent disease brings to millions. It’s that combination of experience that makes David’s journey so powerful.

===

Entrepreneurs: How to get investment from StartUp Health startuphealth.com

Investors: How to invest in StartUp Health Moonshots healthmoonshots.com
Want more content like this? You can subscribe to the podcast as well as other health innovation updates at startuphealth.com/content.
Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.